Примери за използване на Polyangiitis на Английски и техните преводи на Български
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Microscopic polyangiitis fits.
Two inflammatory conditions of blood vessels known as granulomatosis with polyangiitis GPA or.
Granulomatosis with polyangiitis and microscopic polyangiitis.
Contraindications for use in rheumatoid arthritis,granulomatosis with polyangiitis and microscopic polyangiitis.
Granulomatosis with polyangiitis(GPA or Wegener's granulomatosis)and microscopic polyangiitis.
If you are being treated for granulomatosis with polyangiitis or microscopic polyangiitis.
Granulomatosis with polyangiitis and microscopic polyangiitis Patients treated with Truxima must be given the patient alert card with each infusion.
Experience from granulomatosis with polyangiitis and microscopic polyangiitis.
Granulomatosis with polyangiitis and microscopic polyangiitis are two forms of inflammation of the blood vessels, which mainly affects the lungs and the kidneys, but may also affect other organs.
Rheumatoid arthritis, granulomatosis with polyangiitis and microscopic polyangiitis.
In patients with granulomatosis with polyangiitis or microscopic polyangiitis, the number of peripheral blood B cells decreased to.
You have severe heart failure or severe uncontrolled heart disease and have rheumatoid arthritis,granulomatosis with polyangiitis or microscopic polyangiitis.
Granulomatosis with polyangiitis or microscopic polyangiitis.
Ritemvia, in combination with glucocorticoids,is indicated for the treatment of adult patients with severe, active granulomatosis with polyangiitis(Wegener's)(GPA) and microscopic polyangiitis(MPA).
If you have granulomatosis with polyangiitis or microscopic polyangiitis also tell your doctor.
Cases of hepatitis B reactivation, including those with a fatal outcome, have been reported in rheumatoid arthritis,granulomatosis with polyangiitis and microscopic polyangiitis patients receiving rituximab.
IRRs for patients with granulomatosis with polyangiitis and microscopic polyangiitis were similar to those seen for rheumatoid arthritis patients in clinical trials(see section 4.8).
The effect of multiple rituximab courses on the development of neutropenia in granulomatosis with polyangiitis and microscopic polyangiitis patients has not been.
IRRs for patients with granulomatosis with polyangiitis, microscopic polyangiitis and pemphigus vulgaris were consistent with those seen for rheumatoid arthritis patients in clinical trials(see section 4.8).
Hypogammaglobulinaemia(IgA, IgG or IgM below the lower limit of normal)has been observed in granulomatosis with polyangiitis and microscopic polyangiitis patients treated with rituximab.
If you are being treated for granulomatosis with polyangiitis, microscopic polyangiitis or pemphigus vulgaris, you will also find this information in the Patient Alert Card you have been given by your doctor.
MabThera, given in combination with glucocorticoids,used for introduction into remission in granulomatosis with polyangiitis(formerly called Wegener's granulomatosis), and microscopic polyangiitis. .
The limited data from the present trial preclude any conclusions regarding the efficacy of subsequent courses of rituximab in patients with granulomatosis with polyangiitis and microscopic polyangiitis. .
Clinical experience in granulomatosis with polyangiitis(Wegener's) and microscopic polyangiitis.
Pneumocystis jiroveci pneumonia(PCP) prophylaxis is recommended for patients with granulomatosis with polyangiitis or microscopic polyangiitis during and following Rituzena.
Rheumatoid arthritis, granulomatosis with polyangiitis, microscopic polyangiitis, and pemphigus vulgaris.
The effect of multiple MabThera courses on the development of neutropenia in granulomatosis with polyangiitis and microscopic polyangiitis patients has not been studied in clinical trials.
If you have rheumatoid arthritis, granulomatosis with polyangiitis, microscopic polyangiitis or pemphigus vulgaris also tell your doctor.
A small number of cases of hepatitis-B reactivation, some with fatal outcome,have been reported in granulomatosis with polyangiitis and microscopic polyangiitis patients receiving MabThera in the postmarketing setting.
All patients treated with Riximyo for rheumatoid arthritis,granulomatosis with polyangiitis, microscopic polyangiitis or pemphigus vulgaris must be given the patient alert card with each infusion.